前往化源商城

PLoS ONE 2015-01-01

Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function.

Elie Simard, Thomas Söllradl, Jean-Sébastien Maltais, Julie Boucher, Pédro D'Orléans-Juste, Michel Grandbois

文献索引:PLoS ONE 10 , e0128881, (2015)

全文:HTML全文

摘要

Increased blood glucose concentrations promote reactions between glucose and proteins to form advanced glycation end-products (AGE). Circulating AGE in the blood plasma can activate the receptor for advanced end-products (RAGE), which is present on both endothelial and vascular smooth muscle cells (VSMC). RAGE exhibits a complex signaling that involves small G-proteins and mitogen activated protein kinases (MAPK), which lead to increased nuclear factor kappa B (NF-κB) activity. While RAGE signaling has been previously addressed in endothelial cells, little is known regarding its impact on the function of VSMC. Therefore, we hypothesized that RAGE signaling leads to alterations in the mechanical and functional properties of VSMC, which could contribute to complications associated with diabetes. We demonstrated that RAGE is expressed and functional in the A7r5 VSMC model, and its activation by AGE significantly increased NF-κB activity, which is known to interfere with the contractile phenotype of VSMC. The protein levels of the contraction-related transcription factor myocardin were also decreased by RAGE activation with a concomitant decrease in the mRNA and protein levels of transgelin (SM-22α), a regulator of VSMC contraction. Interestingly, we demonstrated that RAGE activation increased the overall cell rigidity, an effect that can be related to an increase in myosin activity. Finally, although RAGE stimulation amplified calcium signaling and slightly myosin activity in VSMC challenged with vasopressin, their contractile capacity was negatively affected. Overall, RAGE activation in VSMC could represent a keystone in the development of vascular diseases associated with diabetes by interfering with the contractile phenotype of VSMC through the modification of their mechanical and functional properties.

相关化合物

结构式 名称/CAS号 全部文献
纯碱 结构式 纯碱
CAS:497-19-8
氯仿 结构式 氯仿
CAS:67-66-3
氯化钠 结构式 氯化钠
CAS:7647-14-5
乙醇 结构式 乙醇
CAS:64-17-5
十二烷基硫酸钠 结构式 十二烷基硫酸钠
CAS:151-21-3
无水氯化钙 结构式 无水氯化钙
CAS:10043-52-4
三(羟甲基)氨基甲烷 结构式 三(羟甲基)氨基甲烷
CAS:77-86-1
3,6-二氧杂-1,8-辛二胺四乙酸(EGTA) 结构式 3,6-二氧杂-1,8-辛二胺四乙酸(EGTA)
CAS:67-42-5
甘氨酸 结构式 甘氨酸
CAS:56-40-6
氯化钠-35cl 结构式 氯化钠-35cl
CAS:20510-55-8